Back to HRT FINANCIAL LP HRT FINANCIAL LP

CTKBCTKB
6 quarters

Position history for HRT FINANCIAL LPHRT FINANCIAL LP's holdings in CYTEK BIOSCIENCES INC

Yes. HRT Financial holds 997,769 shares of CTKB (Cytek Biosciences), worth $4.4M, as of its Q2 2026 13F filing. It increased the position by 583,717 shares (+141.0%) from Q1 2026. HRT Financial has held CTKB since Q4 2025, across 3 quarterly 13F filings.

Current Value

$4.4M

Current Shares

997,769

Total Value Change

+$3.8M

Total Shares Change

+832,464

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
997,769
+141.0%
$4.4M0.0%$4.43
43
2026-Q1
Decreased
414,052
-5.4%
$1.8M0.0%$4.37
0
2025-Q4
New
437,653
-
$2.2M0.0%$5.05
36
2025-Q3
Exited
0
-100.0%
$00.0%$3.47
0
2025-Q2
Decreased
56,620
-65.8%
$192,0000.0%$3.40
0
2025-Q1
New
165,305
-
$662,0000.0%$4.01
34

Other major holders of CTKB: RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used